hotspot -WSS

hotspot

author：focus 2025-09-27 15:49:31 - browse：5

Nick Leschly - Bluebird Bio — Longtime Bluebird Bio CEO Nick Leschly Wendy Maeda/The Boston Globe

Some two years after splitting biotech company Bluebird Bio into two entities in a bid to “sharpen their focus” and improve operations, the spinout focused on oncology treatments announced major cost cuts and is parting ways with its chief executive.

The spinout, 2Seventy Bio, announced Tuesday that it is cutting approximately 40% of its workforce, or about 176 employees. It also plans to allocate less money to a couple of drug candidates, including one that is currently on hold with the Food and Drug Administration. The cuts extend the company’s cash runway into 2026.

The company was formed in 2021 when the team behind Bluebird Bio decided to split its drug pipeline down the middle. The company was wrestling with its gene therapy portfolio, including getting approval for a gene therapy for the blood disorder beta thalassemia in the U.S. Separately, it had a basket of cancer drug candidates and a partnership with pharma company Bristol Myers Squibb that needed attention. So, Bluebird split its operations in two, with longtime CEO Nick Leschly taking the helm at the new firm.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： JPM pitch from hospitals? Revenue streams outside of patient care

hotspot

WSS

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

At JPM 2024, hospital systems pitch financial strength to investors

India sets sights on home

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Boston Scientific acquires urology company Axonics for $3.7 billion

entertainment

hotspot

focus

Peter Hotez and the public health issue of online harassment

Trump got a 'target letter.' What is one and what does it mean?

Continuity nursing helped my family in our darkest PICU moments

Allen Institute goes after foundational questions, CEO Costa says

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Does Paxlovid work in people vaccinated against Covid

The high cost of giving birth even with insurance

Merck to acquire Harpoon Therapeutics for $680 million

At least 13 dead in Texas as scorching temps continue

Plane’s emergency slide plummets from sky, hits Chicago home

focus

Researchers separate signal from noise in heart wearable data

Plane’s emergency slide plummets from sky, hits Chicago home

Medicare Advantage coverage denials need scrutiny, senators say

New warning issued for rebooking air travel after delays, cancellations

Ascension's ugly legal battle over care for poor patients in Texas

Merck to acquire Harpoon Therapeutics for $680 million

hotspot

hotspot

hotspot

focus